No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation

The diagnosis of chronic mountain sickness (CMS) is based on a score including 7 clinical features (breathlessness, sleep disturbance, cyanosis, venous dilatation, paresthesia, headache, and tinnitus) in the setting of extreme erythrocytosis. Examining individuals in La Rinconada, Peru, the highest...

Descripción completa

Detalles Bibliográficos
Autores principales: Cappy, Pierre, Candotti, Daniel, Sauvage, Virginie, Lucas, Quentin, Boizeau, Laure, Gomez, Johanna, Enouf, Vincent, Chabli, Lila, Pillonel, Josiane, Tiberghien, Pierre, Morel, Pascal, Laperche, Syria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
Letter to Blood
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568032/
https://www.ncbi.nlm.nih.gov/pubmed/32871595
http://dx.doi.org/10.1182/blood.2020008230
Descripción
Sumario:The diagnosis of chronic mountain sickness (CMS) is based on a score including 7 clinical features (breathlessness, sleep disturbance, cyanosis, venous dilatation, paresthesia, headache, and tinnitus) in the setting of extreme erythrocytosis. Examining individuals in La Rinconada, Peru, the highest city in the world, the authors demonstrated that CMS at extreme altitude is not linked to elevation of hemoglobin, since CMS(+) and CMS(−) individuals had similar levels of erythrocytosis.

Ejemplares similares